AstraZeneca’s fixed-dose triple-combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials in asthma: Cambridge, UK Saturday, May 3, 2025, 10:00 Hrs ...

University of East Anglia (UEA) scientists have developed a revolutionary new way of uncovering the ‘true age’ of your heart using MRI. Research published shows how an MRI scan can reveal your heart’s ...

India’s Healthtech boom faces tough test to balance personalisation and data privacy: Vineet Mehta: Shardul Nautiyal, Mumbai Saturday, May 3, 2025, 08:00 Hrs [IST] In India, hea ...

High Court quashes IPO's decision to hear pre-grant opposition after signing patent approval: Gireesh Babu, New Delhi Saturday, May 3, 2025, 08:00 Hrs [IST] The Delhi High Court h ...

Upcoming B Pharm curriculum will overhaul pharmacy education at graduate level: Experts: Peethaambaran Kunnathoor, Chennai Saturday, May 3, 2025, 08:00 Hrs [IST] Eminent academici ...

DGFT eases pharma export rules for SCOMET items for testing and evaluation: Shardul Nautiyal, Mumbai Saturday, May 3, 2025, 08:00 Hrs [IST] In a move to facilitate technological a ...

The Central Drugs Standard Control Organisation (CDSCO) has announced changes in the public hearing schedule by various divisions for stakeholders to get regulatory guidance from the drug regulator's ...

Apollo Diagnostics revolutionizes diagnostics with Digi-Smart Lab: Our Bureau, Mumbai Friday, May 2, 2025, 14:15 Hrs [IST] ...

Genocury Biotech announces positive results from noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma: Shenzhen, China Friday, May 2, 2025, 15:00 ...

The National Institutes of Health (NIH) is adopting a new initiative to expand innovative, human-based science while reducing animal use in research. Developing and using cutting-edge alternative ...

PL BioScience introduces patented gamma-irradiated Human Platelet Lysate, ELAREM Ultimate-FD PLUS: Aachen, Germany Friday, May 2, 2025, 16:00 Hrs [IST] PL BioScience GmbH, a Germa ...

Novartis inks agreement to buy Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD: Basel Friday, May 2, 2025, 14:00 Hrs [IST] Novartis annou ...